Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
PR Newswire•23/07/2026•13:00 ET
0
Whiz Insights
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Veteran pharmaceutical executive to lead Tessera's next phase of growth as the company advances Gene Writing from platform innovation toward a broad clinical pipeline of genetic medicines
Get started
Create a free account to read the full story.